KYNTRA BIO, INC. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
KYNTRA BIO, INC. (KYNB) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $153.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2021-11-09
- 2021-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $153.00K.
- 2021-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $146.00K.
- 2021-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $129.00K.
- 2020-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $119.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2021-09-30 | $153.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $146.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $129.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $119.00K 10-Q · filed 2021-11-09 |
| 2020-09-30 | $527.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.30M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.73M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $784.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $894.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.24M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $695.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $238.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $145.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $120.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.25M 10-K · filed 2019-02-27 |
| 2017-09-30 | $1.21M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $872.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $431.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $439.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $794.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $1.02M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $634.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $125.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | $383.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $362.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $865.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $331.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |